Found 175 clinical trials
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression
This is a randomized, double-blind, placebo-controlled, multicenter, Phase 3 study to evaluate if high-dose Octagam 10% therapy can stabilize or improve clinical status in patients with severe Coronavirus disease
- 0 views
- 19 Feb, 2024
PCSK9i in AAA123
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 18 Mar, 2025
- 1 location
1 march 4
This is a randomized, open-label, parallel group study to determine the optimal dose of CART-19 cells (of the two dose levels being assessed (1-5x10xE8 vs. 1-5x10xE7 CART-19 cells). This trial will be conducted in two stages. In Stage 2, the selected dose cohort will be expanded to enroll additional subjects, …
- 0 views
- 19 Feb, 2024
- 1 location
